(3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide

C10H17N5O3S — CID 172908615

IUPAC(3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide
SMILESCn1cc(NS(=O)(=O)N2CCC[C@H](C(N)=O)C2)cn1
InChIInChI=1S/C10H17N5O3S/c1-14-7-9(5-12-14)13-19(17,18)15-4-2-3-8(6-15)10(11)16/h5,7-8,13H,2-4,6H2,1H3,(H2,11,16)/t8-/m0/s1
InChIKeyLHMBTQSMJAKEKA-QMMMGPOBSA-N
MW287.34 g/mol
LogP-0.73
Rot. Bonds4

About (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide

(3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide (PubChem CID 172908615) has the molecular formula C10H17N5O3S and a molecular weight of 287.34 g/mol. Its IUPAC name is (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide.

Molecular Properties

Compound Name(3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide
PubChem CID172908615
Molecular FormulaC10H17N5O3S
Molecular Weight287.34 g/mol
Exact Mass287.11
IUPAC Name(3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide
SMILESCn1cc(NS(=O)(=O)N2CCC[C@H](C(N)=O)C2)cn1
InChIInChI=1S/C10H17N5O3S/c1-14-7-9(5-12-14)13-19(17,18)15-4-2-3-8(6-15)10(11)16/h5,7-8,13H,2-4,6H2,1H3,(H2,11,16)/t8-/m0/s1
InChIKeyLHMBTQSMJAKEKA-QMMMGPOBSA-N
XLogP-0.73
TPSA110.32 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500287.34
LogP ≤ 5-0.73
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(1-ethyl-1H-pyrazol-4-yl)cyclobutanecarboxamide
CID 51114235
3-amino-1-(1-methyl-1H-pyrazol-4-yl)piperidin-2-one
CID 54593545
N-[1-(ethoxymethyl)-1H-pyrazol-4-yl]-1-(methylsulfonyl)piperidine-4-carboxamide
CID 19582140
1-(methylsulfonyl)-N-{1-[(2,2,2-trifluoroethoxy)methyl]-1H-pyrazol-4-yl}piperidine-3-carboxamide
CID 19583515
1-[1-(tert-butylamino)-1-oxopropan-2-yl]-N-(1-ethylpyrazol-4-yl)piperidine-4-carboxamide
CID 51098378
N-(1-ethylpyrazol-4-yl)-1-[2-(2-methylpropylamino)-2-oxoethyl]piperidine-4-carboxamide
CID 51098382
N-(1-ethylpyrazol-4-yl)-1-[2-oxo-2-(propylamino)ethyl]piperidine-4-carboxamide
CID 51098383
N-(1-ethylpyrazol-4-yl)-1-[2-(2-methylbutan-2-ylamino)-2-oxoethyl]piperidine-4-carboxamide
CID 53602398
1-[5-Oxo-1-(1-propan-2-ylpyrazol-4-yl)pyrrolidine-3-carbonyl]piperidine-4-carboxamide
CID 71830373
N-(1-ethyl-1H-pyrazol-4-yl)piperidine-4-carboxamide dihydrochloride
CID 45792389
4-methyl-N-[2-[methyl-(1-methylpyrazol-4-yl)amino]-2-oxoethyl]pentanamide
CID 71986184
(4S)-N-(1-ethylpyrazol-4-yl)-1-methyl-2-oxopiperidine-4-carboxamide
CID 97311350

Frequently Asked Questions

What is the IUPAC name of (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide?
The IUPAC name of (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide (CID 172908615) is (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide.
What is the SMILES notation for (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide?
The canonical SMILES for (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide is Cn1cc(NS(=O)(=O)N2CCC[C@H](C(N)=O)C2)cn1.
What is the InChIKey of (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide?
The InChIKey is LHMBTQSMJAKEKA-QMMMGPOBSA-N. The full InChI is InChI=1S/C10H17N5O3S/c1-14-7-9(5-12-14)13-19(17,18)15-4-2-3-8(6-15)10(11)16/h5,7-8,13H,2-4,6H2,1H3,(H2,11,16)/t8-/m0/s1.
What are the key properties of (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide?
(3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide has a molecular weight of 287.34 g/mol, XLogP of -0.73, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-1-[(1-methylpyrazol-4-yl)sulfamoyl]piperidine-3-carboxamide is sourced from PubChem (CID 172908615), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).